Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 24.73
+0.44 (1.81%)
Jan 28, 2026, 9:30 AM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.34 billion as of January 27, 2026. Its market cap has decreased by -67.82% in one year.
Market Cap
1.34B
Enterprise Value
1.52B
Revenue
2.76B
Ranking
n/a
PE Ratio
9.28
Stock Price
24.73
Market Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.34B, an increase of 3,131.61%. That is a compound annual growth rate of 40.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 1.34B | -9.60% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 332.70B |
| OneSource Specialty Pharma | 131.92B |
| Concord Biotech | 127.84B |
| Blue Jet Healthcare | 75.02B |
| Supriya Lifescience | 55.05B |
| Zota Health Care | 40.27B |
| Dishman Carbogen Amcis | 31.84B |
| Panacea Biotec | 22.30B |